The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services. The best practices research and insight programs provide the foundation for all of its other programs. The Company offers technology analytics programs anchored by cloud-based software applications that surface performance improvement opportunities to accelerate progress. Through its consulting services, the Company provides on-the-ground support for performance improvement initiatives, as well as best practice professional management of areas of the hospital or medical group. The Company's data-enabled services are primarily focused in the area of enrollment management.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryResearch & Consulting Services
SectorN/A
SymbolNASDAQ:ABCO
CUSIP00762W10
Phone+1-202-2665600
Debt
Debt-to-Equity Ratio0.98
Current Ratio1.07
Quick Ratio1.07
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E Ratio35.88
P/E Growth2.4
Sales & Book Value
Annual Sales$803.42 million
Price / Sales2.73
Cash Flow$3.7535 per share
Price / Cash14.34
Book Value$12.88 per share
Price / Book4.18
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$91.23 million
Net Margins-3.42%
Return on Equity0.48%
Return on Assets-1.23%
Miscellaneous
Employees3,800
Outstanding Shares40,760,000
Market Cap$2.19 billion
The Advisory Board (NASDAQ:ABCO) Frequently Asked Questions
What is The Advisory Board's stock symbol?
The Advisory Board trades on the NASDAQ under the ticker symbol "ABCO."
How were The Advisory Board's earnings last quarter?
The Advisory Board Company (NASDAQ:ABCO) released its quarterly earnings data on Wednesday, July, 27th. The business services provider reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.13. The business services provider earned $198.40 million during the quarter, compared to the consensus estimate of $196.49 million. The Advisory Board had a negative net margin of 3.42% and a positive return on equity of 0.48%. The Advisory Board's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.40 earnings per share. View The Advisory Board's Earnings History.
What price target have analysts set for ABCO?
6 analysts have issued 12 month price objectives for The Advisory Board's stock. Their predictions range from $54.00 to $54.29. On average, they expect The Advisory Board's share price to reach $54.0725 in the next year. This suggests a possible upside of 0.5% from the stock's current price. View Analyst Price Targets for The Advisory Board.
What is the consensus analysts' recommendation for The Advisory Board?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Advisory Board in the last year. There are currently 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for The Advisory Board.
Who are The Advisory Board's key executives?
The Advisory Board's management team includes the folowing people:
- Robert W. Musslewhite J.D., Chairman of the Board, Chief Executive Officer (Age 47)
- David L. Felsenthal, President, Director (Age 46)
- Michael T. Kirshbaum, Chief Financial Officer, Treasurer (Age 40)
- Richard A. Schwartz Ph.D., Chief Operating Officer - Health Care (Age 51)
- Cormac F. Miller, Chief Product Officer (Age 43)
- Mary D. Van Hoose, Chief Talent Officer (Age 52)
- Evan R. Farber, Chief Legal Officer and Corporate Secretary (Age 44)
- Kelt Kindick, Lead Independent Director (Age 62)
- Sanjeev K. Bansal, Independent Director (Age 51)
- Peter J. Grua, Independent Director (Age 63)
Has The Advisory Board been receiving favorable news coverage?
News articles about ABCO stock have been trending positive recently, Accern reports. Accern scores the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. The Advisory Board earned a media and rumor sentiment score of 0.26 on Accern's scale. They also assigned news stories about the business services provider an impact score of 48.53 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. View Recent Headlines for The Advisory Board.
How do I buy shares of The Advisory Board?
Shares of ABCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is The Advisory Board's stock price today?
One share of ABCO stock can currently be purchased for approximately $53.8250.
How big of a company is The Advisory Board?
The Advisory Board has a market capitalization of $2.19 billion and generates $803.42 million in revenue each year. The Advisory Board employs 3,800 workers across the globe.
How can I contact The Advisory Board?
The Advisory Board's mailing address is 2445 M St NW, WASHINGTON, DC 20037-1435, United States. The business services provider can be reached via phone at +1-202-2665600 or via email at [email protected]
MarketBeat Community Rating for The Advisory Board (NASDAQ ABCO)
MarketBeat's community ratings are surveys of what our community members think about The Advisory Board and other stocks. Vote "Outperform" if you believe ABCO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABCO will underperform the S&P 500 over the long term. You may vote once every thirty days.
